-
1
-
-
34548682552
-
Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients
-
Chen C.H., Huang M.C., Lu M.L. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients. J Clin Psychopharmacol 2007, 27:516-517.
-
(2007)
J Clin Psychopharmacol
, vol.27
, pp. 516-517
-
-
Chen, C.H.1
Huang, M.C.2
Lu, M.L.3
-
2
-
-
40049086110
-
Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient
-
Chen C.H., Huang M.C., Lu M.L. Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:893-894.
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 893-894
-
-
Chen, C.H.1
Huang, M.C.2
Lu, M.L.3
-
3
-
-
47749112800
-
Combined antipsychotic treatment involving clozapine and aripiprazole
-
Englisch S., Zink M. Combined antipsychotic treatment involving clozapine and aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1386-1392.
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 1386-1392
-
-
Englisch, S.1
Zink, M.2
-
4
-
-
33646818313
-
Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia
-
Horacek J., Bubenikova-Valesova V., Kopecek M., Palenicek T., Dockery C., Mohr P., et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 2006, 20:389-409.
-
(2006)
CNS Drugs
, vol.20
, pp. 389-409
-
-
Horacek, J.1
Bubenikova-Valesova, V.2
Kopecek, M.3
Palenicek, T.4
Dockery, C.5
Mohr, P.6
-
5
-
-
33846829749
-
Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: an open-label pilot study
-
Mitsonis C.I., Dimopoulos N.P., Mitropoulos P.A., Kararizou E.G., Katsa A.N., Tsakiris F.E., et al. Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: an open-label pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:373-377.
-
(2007)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.31
, pp. 373-377
-
-
Mitsonis, C.I.1
Dimopoulos, N.P.2
Mitropoulos, P.A.3
Kararizou, E.G.4
Katsa, A.N.5
Tsakiris, F.E.6
-
6
-
-
9944225707
-
Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism
-
Naber D., Lambert M. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1213-1219.
-
(2004)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.28
, pp. 1213-1219
-
-
Naber, D.1
Lambert, M.2
-
7
-
-
33846298474
-
Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole
-
Raja M. Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole. Int J Neuropsychopharmacol 2007, 10:107-110.
-
(2007)
Int J Neuropsychopharmacol
, vol.10
, pp. 107-110
-
-
Raja, M.1
-
8
-
-
1642452858
-
Aripiprazole possibly worsens psychosis
-
Ramaswamy S., Vijay D., William M., Sattar S.P., Praveen F., Petty F. Aripiprazole possibly worsens psychosis. Int Clin Psychopharmacol 2004, 19:45-48.
-
(2004)
Int Clin Psychopharmacol
, vol.19
, pp. 45-48
-
-
Ramaswamy, S.1
Vijay, D.2
William, M.3
Sattar, S.P.4
Praveen, F.5
Petty, F.6
-
9
-
-
3042699593
-
Worsening schizoaffective disorder with aripiprazole
-
Reeves R.R., Mack J.E. Worsening schizoaffective disorder with aripiprazole. Am J Psychiatry 2004, 161:1308.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1308
-
-
Reeves, R.R.1
Mack, J.E.2
-
10
-
-
0042887023
-
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
-
Shapiro D.A., Renock S., Arrington E., Chiodo L.A., Liu L.X., Sibley D.R., et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 2003, 28:1400-1411.
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 1400-1411
-
-
Shapiro, D.A.1
Renock, S.2
Arrington, E.3
Chiodo, L.A.4
Liu, L.X.5
Sibley, D.R.6
|